Tizanidine Tablet
Product Images NDC 68071-3440

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 68071-3440). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Pdp (68071 3440 9)

Pdp (68071 3440 9)
FDA Label Image

Fig1 (Fig1)

Fig1 (Fig1)
FDA Label Image

Fig2 (Fig2)

Fig2 (Fig2)
FDA Label Image

Fig3 (Fig3)

Fig3 (Fig3)
Improvement in Ashworth Score is being studied in this evaluation. The drug being tested is Zanidine, with an average dose of 28.6 mg. The study is conducted for a duration of 7 weeks, with the measurement of Ashworth Score taken at week 3 and the final observation recorded at the end of the maintenance period.*
FDA Label Image

Structure (Structure)

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.